Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Lung Neoplasms
  • Mutation
  • Receptor, ErbB-2

abstract

  • HER2 mutations identify a distinct subset of lung ADCs. Given the high prevalence of lung cancer worldwide and the availability of standard and investigational therapies targeting HER2, routine clinical genotyping of lung ADC should include HER2.

publication date

  • September 15, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3865806

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.CCR-12-0912

PubMed ID

  • 22761469

Additional Document Info

start page

  • 4910

end page

  • 8

volume

  • 18

number

  • 18